Therapeutic targets in age-related macular disease.
Age-related macular disease (AMD) accounts for more than 50% of blind registration in Western society. Patients with AMD are classified as having early disease, in which visual function is well preserved, or late disease, in which central vision is lost. Until recently, there was no therapy available by which the course of the disorder could be modified. Now, the most common form of late-stage AMD - choroidal neovascularization - responds to treatment with anti-VEGF therapies; although visual loss is modified in a portion of these cases, no therapeutic approach exists that alters the evolution from early to late disease. However, as discussed in this Review, research over the last few years has demonstrated several features of AMD that are likely to be amenable to treatment. Potential targets for treatment are described, and possible therapeutic approaches are discussed.
Bird
Alan C
AC
Institute of Ophthalmology, University College London, and Moorfields Eye Hospital, London, UK. Alan.bird@ucl.ac.uk
D000375:Aging; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D001766:Blindness / Q000188:drug therapy; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D004195:Disease Models, Animal; D005123:Eye / Q000033:anatomy & histology / Q000473:pathology / Q000648:ultrastructure; D006801:Humans; D008268:Macular Degeneration / Q000145:classification / Q000188:drug therapy* / Q000628:therapy; D051379:Mice; D018345:Mice, Knockout; D051381:Rats; D017207:Rats, Sprague-Dawley; D012106:Research / Q000639:trends; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A
Ophthalmology. 1995 Oct;102(10):1450-60
9097791
Br J Ophthalmol. 1996 Jan;80(1):9-14
8664242
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3095-9
18378583
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2576-86
15980251
Graefes Arch Clin Exp Ophthalmol. 1991;229(5):406-10
1937071
Trans Ophthalmol Soc U K. 1983;103 ( Pt 4):416-21
6589859
Invest Ophthalmol Vis Sci. 1992 Feb;33(2):334-40
1740363
Nat Genet. 2008 Jul;40(7):892-6
18511946
Science. 2005 Apr 15;308(5720):419-21
15761120
Invest Ophthalmol Vis Sci. 1997 Mar;38(3):762-7
9071230
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16651-6
17921253
Curr Eye Res. 1999 Mar;18(3):203-13
10342375
Ophthalmology. 1993 Jan;100(1):47-51
8433826
Science. 2005 Apr 15;308(5720):385-9
15761122
Ophthalmology. 1992 Oct;99(10):1548-53
1454321
Ophthalmology. 1985 May;92(5):628-35
2409505
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
15870199
Prog Retin Eye Res. 2010 Mar;29(2):95-112
19961953
Jpn J Ophthalmol. 1991;35(3):268-72
1770666
J Clin Invest. 2005 Oct;115(10):2793-800
16167083
Br J Ophthalmol. 1988 Dec;72(12):918-20
3228547
Albrecht Von Graefes Arch Ophthalmol. 1948;148(3-4):287-317
18868814
Trans Am Ophthalmol Soc. 1977;75:180-254
613523
Invest Ophthalmol Vis Sci. 1994 May;35(6):2857-64
8188481
Am J Ophthalmol. 2002 Mar;133(3):341-9
11860971
Ann Med. 2006;38(8):592-604
17438673
Invest Ophthalmol Vis Sci. 1990 May;31(5):899-908
1692312
Br J Ophthalmol. 1993 Sep;77(9):549-54
8218049
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7154-9
10852960
Br J Ophthalmol. 1995 May;79(5):407-12
7612549
Am J Ophthalmol. 1988 Mar 15;105(3):285-90
2449819
Arch Ophthalmol. 1995 Jun;113(6):728-35
7786213
N Engl J Med. 2007 Aug 9;357(6):553-61
17634448
Hum Mol Genet. 2005 Nov 1;14(21):3227-36
16174643
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3612-24
16877436
Jpn J Ophthalmol. 1991;35(1):87-95
1716707
Am J Ophthalmol. 2008 Oct;146(4):496-500
18639219
Exp Eye Res. 2009 Feb;88(2):195-203
18588875
N Engl J Med. 2006 Oct 5;355(14):1474-85
17021323
Arch Ophthalmol. 1994 Mar;112(3):402-6
8129668
Acta Ophthalmol Scand. 2006 Oct;84(5):636-41
16965494
Am J Pathol. 1999 Aug;155(2):421-8
10433935
Am J Ophthalmol. 1990 Feb 15;109(2):211-7
2301534
Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2088-96
12091401
J Mol Biol. 2008 Dec 31;384(5):1341-52
18976665
Neuroscience. 2009 Aug 18;162(2):375-82
19422885
Exp Eye Res. 2007 Apr;84(4):772-80
17313944
Invest Ophthalmol Vis Sci. 1995 Mar;36(3):718-29
7890502
Prog Retin Eye Res. 2003 Jan;22(1):1-29
12597922
Ophthalmology. 2007 Jun;114(6):1157-63
17337063
Arctic Med Res. 1987 Oct;46(2):64-70
3426774
Invest Ophthalmol Vis Sci. 2001 Apr;42(5):1051-6
11274085
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11026-31
17578916
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1275-81
20185837
Ophthalmology. 1989 Dec;96(12):1769-77
2482957
Trans Am Acad Ophthalmol Otolaryngol. 1965 Jul-Aug;69:683-90
14345773
Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4305-12
11095631
Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):651-9
19214553
Eur J Hum Genet. 2009 Sep;17(9):1190-9
19259132
J Alzheimers Dis. 2009;16(3):471-83
19276540
Retina. 2001;21(5):416-34
11642370
Prog Retin Eye Res. 2001 Nov;20(6):705-32
11587915
Exp Eye Res. 2004 Feb;78(2):243-56
14729357
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4982-91
19357355
Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):905-9
7846076
Ophthalmology. 1991 Jun;98(6):953-6
1866150
J Lipid Res. 1991 Dec;32(12):2009-17
1840067
Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1929-34
8759365
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1236-49
8641827
Invest Ophthalmol Vis Sci. 2002 May;43(5):1574-80
11980876
Arch Ophthalmol. 1964 Jun;71:842-50
14133872
Invest Ophthalmol Vis Sci. 1999 Feb;40(2):443-9
9950604
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):737-43
10067978
Invest Ophthalmol Vis Sci. 1984 Oct;25(10):1135-45
6480292
Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34
11033038
Med Sci Monit. 2010 Jan;16(1):BR17-23
20037481
Br J Ophthalmol. 1976 May;60(5):324-41
952802
Zhonghua Yi Xue Za Zhi (Taipei). 1995 Dec;56(6):411-7
8851483
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1392-9
19029031
Science. 2005 Apr 15;308(5720):421-4
15761121
Nippon Ganka Gakkai Zasshi. 1988 Oct;92(10):1629-36
2463748
Ann Acad Med Singap. 2002 May;31(3):399-404
12061304
Exp Eye Res. 2006 Jan;82(1):99-110
16019000
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1304-10
19892876
Trans Am Acad Ophthalmol Otolaryngol. 1972 Jan-Feb;76(1):64-80
5024602
J Formos Med Assoc. 1993 Sep;92(9):823-8
7507372
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11830-5
12189211
Ophthalmology. 1992 Jun;99(6):933-43
1630784
Eye (Lond). 1989;3 ( Pt 5):588-96
2630336
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18751-6
19841260
Exp Eye Res. 1992 Feb;54(2):239-46
1559552
Ophthalmology. 1995 Feb;102(2):205-10
7862408
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):574-83
14744901
Arch Ophthalmol. 2003 Mar;121(3):379-85
12617709
Am J Ophthalmol. 2000 Nov;130(5):658-63
11078846
Ophthalmology. 1989 Dec;96(12):1763-8
2622621
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4137-44
18487363
Am J Ophthalmol. 2007 Dec;144(6):850-857
17949673
FASEB J. 1999 Mar;13(3):477-84
10064614
Graefes Arch Clin Exp Ophthalmol. 2002 Dec;240(12):983-8
12483320
Am J Pathol. 1994 Sep;145(3):574-84
7521577
Mol Vis. 2006 Dec 22;12:1649-59
17200665
Br J Ophthalmol. 1978 Aug;62(8):547-50
687553
Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1290-7
7775106
Ophthalmology. 1990 Feb;97(2):171-8
1691475
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4742-7
12671074
Exp Eye Res. 2007 Dec;85(6):762-71
17915218
J Neurochem. 1991 Nov;57(5):1690-9
1833510
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5304-9
19407013
BMJ. 2003 Feb 1;326(7383):255-6
12560276
Ophthalmology. 2007 Feb;114(2):246-52
17270674
Arctic Med Res. 1987;46(1):13-7
3675777
Trans Ophthalmol Soc U K. 1986;105 ( Pt 6):674-82
3310342